Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Adaptive Biotechnologies
Pharmaceutical Preparation ManufacturingUnited StatesNASDAQ: ADPT
Last verified 10 months agoadaptivebiotech.com
Adaptive Biotechnologies Corporation, headquartered in the United States, is a pioneering leader in the biotechnology industry, specialising in immune-driven medicine. Founded in 2009, the company has made significant strides in harnessing the power of the adaptive immune system to develop innovative diagnostic and therapeutic solutions.
With a focus on areas such as oncology and infectious diseases, Adaptive Biotechnologies offers unique products like the clonoSEQ® assay, which provides precise insights into the immune repertoire. This technology stands out for its ability to detect and quantify specific immune cells, enabling personalised treatment strategies.
Recognised for its contributions to precision medicine, Adaptive Biotechnologies has established a strong market position, collaborating with major pharmaceutical companies and research institutions to advance the field of immunology.
26
DitchCarbon score
-16 vs industry average
Adaptive Biotechnologies’s score of 26 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Adaptive Biotechnologies?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Adaptive Biotechnologies yet.
Adaptive Biotechnologies's reported carbon emissions
Adaptive Biotechnologies, headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. However, the company is committed to reducing its carbon footprint and has set near-term targets as part of its climate strategy.
As of June 5, 2025, Adaptive Biotechnologies has committed to near-term reduction targets, although specific numerical goals have not been disclosed. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focusing on sustainability and climate action.
While no absolute emissions figures are available, Adaptive Biotechnologies is actively engaging in initiatives to address climate change and improve its environmental impact. The absence of emissions data does not diminish the company's commitment to sustainability, as it aligns with industry standards and practices aimed at reducing greenhouse gas emissions.
Assessing Adaptive Biotechnologies as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Adaptive Biotechnologies and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Adaptive Biotechnologies’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Adaptive Biotechnologies10 months ago
26
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more